X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11222) 11222
Newsletter (131) 131
Magazine Article (17) 17
Book Chapter (8) 8
Book Review (5) 5
Publication (5) 5
Conference Proceeding (2) 2
Dissertation (2) 2
Newspaper Article (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8738) 8738
interferon-alpha - pharmacology (4085) 4085
male (3306) 3306
female (3185) 3185
animals (3176) 3176
interferon-alpha (3012) 3012
pharmacology & pharmacy (2496) 2496
middle aged (2241) 2241
interferon-alpha - therapeutic use (2235) 2235
adult (2227) 2227
recombinant proteins (2124) 2124
interferon (1952) 1952
immunology (1825) 1825
mice (1792) 1792
oncology (1745) 1745
antiviral agents - pharmacology (1449) 1449
antiviral agents - therapeutic use (1425) 1425
aged (1310) 1310
interferon-alpha - administration & dosage (1190) 1190
treatment outcome (1164) 1164
expression (1142) 1142
cells, cultured (1103) 1103
therapy (1079) 1079
hepatitis c, chronic - drug therapy (1066) 1066
drug therapy, combination (964) 964
cell line (960) 960
biochemistry & molecular biology (947) 947
virology (945) 945
biological response modifiers (930) 930
interferon alpha (851) 851
ribavirin - therapeutic use (850) 850
hepatitis c (826) 826
cell biology (787) 787
cancer (774) 774
tumor cells, cultured (747) 747
health aspects (745) 745
activation (734) 734
ribavirin (716) 716
infection (709) 709
cell line, tumor (705) 705
interferon-alpha - adverse effects (702) 702
medicine, research & experimental (702) 702
hepacivirus - drug effects (692) 692
gastroenterology & hepatology (683) 683
cytokines (668) 668
dose-response relationship, drug (664) 664
interferon-gamma - pharmacology (661) 661
antineoplastic agents - pharmacology (656) 656
interferon-alpha - metabolism (649) 649
hepatitis c virus (644) 644
time factors (628) 628
polyethylene glycols - therapeutic use (617) 617
infectious diseases (602) 602
hepacivirus - genetics (600) 600
signal transduction (573) 573
cells (571) 571
antineoplastic agents - therapeutic use (564) 564
hematology (561) 561
apoptosis (547) 547
virus replication - drug effects (539) 539
research (533) 533
analysis (515) 515
care and treatment (511) 511
hepatitis c - drug therapy (507) 507
viruses (503) 503
immunotherapy (495) 495
phosphorylation (494) 494
antiviral agents - administration & dosage (492) 492
dendritic cells (488) 488
virus diseases (481) 481
gene-expression (475) 475
induction (475) 475
genotype (472) 472
interferon-alpha - immunology (467) 467
proteins (466) 466
molecular sequence data (464) 464
gene expression (463) 463
research article (452) 452
carcinoma, renal cell - drug therapy (451) 451
kidney neoplasms - drug therapy (445) 445
recombinant proteins - pharmacology (444) 444
antineoplastic combined chemotherapy protocols - therapeutic use (441) 441
interferon-beta - pharmacology (436) 436
cell division - drug effects (432) 432
signal transduction - drug effects (432) 432
drug therapy (426) 426
mice, inbred c57bl (425) 425
ifn-alpha (423) 423
rats (421) 421
in-vitro (419) 419
hepatitis (417) 417
apoptosis - drug effects (413) 413
adolescent (411) 411
interferon-alpha - biosynthesis (406) 406
ribavirin - pharmacology (404) 404
drug synergism (403) 403
virus-infection (399) 399
interferon alpha-2 (393) 393
flow cytometry (391) 391
hepatitis c, chronic - virology (390) 390
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11075) 11075
Chinese (183) 183
Russian (120) 120
Japanese (76) 76
French (50) 50
Spanish (37) 37
German (24) 24
Portuguese (23) 23
Polish (20) 20
Italian (7) 7
Hungarian (6) 6
Dutch (5) 5
Turkish (3) 3
Ukrainian (3) 3
Arabic (1) 1
Hebrew (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antiviral research, ISSN 0166-3542, 02/2016, Volume 126, pp. 69 - 80
Influenza A viruses (IAVs) impact the public health and global economy by causing yearly epidemics and occasional pandemics. Several anti-IAV drugs are... 
Antiviral agents | Innate immunity | Virus-host interaction | Immune responses | Influenza A virus | HUMAN MACROPHAGES | INFLUENZA-A-VIRUS | VIRAL-INFECTIONS | NS1 PROTEIN | RNA-BINDING | ANTIVIRAL RESPONSES | NEURAMINIDASE INHIBITORS | VIROLOGY | EPITHELIAL-CELLS | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | PYRIMIDINE BIOSYNTHESIS | Interferon-alpha - drug effects | Coinfection - drug therapy | Humans | Deoxycytidine - pharmacology | Phosphoproteins - metabolism | Salicylates - pharmacology | Macrophages - virology | Influenza, Human - virology | Antineoplastic Agents - pharmacology | Influenza, Human - drug therapy | Macrophages - immunology | Amides - pharmacology | Influenza A virus - physiology | Virus Replication - drug effects | Antiviral Agents - pharmacology | Cytokines - metabolism | Immunity, Innate - drug effects | RNA, Viral - biosynthesis | Cells, Cultured | Coinfection - virology | Interferon-alpha - immunology | Pyrroles - pharmacology | Lipopolysaccharides - pharmacology | Macrophages - drug effects | Oxazoles - pharmacology | Thiazoles - pharmacology | Influenza A virus - drug effects | Virus Replication - physiology | Deoxycytidine - analogs & derivatives | Immunologic Factors - pharmacology | Influenza, Human - immunology | Epidemics | Analysis | Influenza | Interferon alpha | Global economy | Biological response modifiers | Health aspects
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2012, Volume 56, Issue 11, pp. 5728 - 5734
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2013, Volume 57, Issue 3, pp. 1312 - 1322
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2014, Volume 58, Issue 2, pp. 647 - 653
Journal Article
Journal of hepatology, ISSN 0168-8278, 2015, Volume 62, Issue 5, pp. 1008 - 1014
Journal Article
Gastroenterology, ISSN 0016-5085, 2011, Volume 141, Issue 3, pp. 881 - 889.e1
Background & Aims We evaluated antiviral activity of 2 weeks therapy with telaprevir alone, peginterferon alfa-2a and ribavirin (PR), or all 3 drugs (TPR) in... 
Gastroenterology and Hepatology | Clinical Trial | Liver Disease | C209 | VX-950 | VX-951 | THERAPY | HEPATITIS-C VIRUS | COMBINATION | INHIBITOR | GASTROENTEROLOGY & HEPATOLOGY | Recombinant Proteins - therapeutic use | Single-Blind Method | Hepatitis C, Chronic - metabolism | Interferon-alpha - pharmacology | Humans | Middle Aged | Hepacivirus - genetics | Polyethylene Glycols - adverse effects | Male | RNA, Viral - blood | Recombinant Proteins - adverse effects | Oligopeptides - adverse effects | Polyethylene Glycols - therapeutic use | Oligopeptides - therapeutic use | Dose-Response Relationship, Drug | RNA, Viral - genetics | Adult | Female | Drug Therapy, Combination | Polyethylene Glycols - pharmacology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Treatment Outcome | Recombinant Proteins - pharmacology | Hepatitis C, Chronic - drug therapy | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Interferon-alpha - adverse effects | Hepatitis C, Chronic - genetics | Oligopeptides - pharmacology | RNA, Viral - drug effects | Ribavirin - pharmacology | Evaluation | Complications and side effects | Care and treatment | RNA | Interferon | Genetic aspects | Hepatitis C | Hepatitis C virus | Consulting services | Ribavirin
Journal Article
Journal of hepatology, ISSN 0168-8278, 2014, Volume 61, Issue 3, pp. 538 - 543
Background & Aims Chronic hepatitis C virus (HCV) infection is characterised by a failure of virus-specific CD8+ T cells that is mainly caused by viral escape... 
Gastroenterology and Hepatology | T cell exhaustion | Antiviral therapy | Immune response | Hepatitis C virus | T cell restoration | DAA | CD127 EXPRESSION | PHENOTYPE | CD8(+) T-CELLS | RESPONSES | INHIBITION | HEPATITIS-C VIRUS | CD4(+) | INFECTION | VIRAL PERSISTENCE | GASTROENTEROLOGY & HEPATOLOGY | PD-1 | Acrylates - therapeutic use | Hepatitis C, Chronic - pathology | CD8-Positive T-Lymphocytes - pathology | Humans | Middle Aged | Male | Recombinant Proteins | Thiazoles - therapeutic use | Contraindications | Oligopeptides - therapeutic use | Acrylates - pharmacology | Adult | Female | Hepacivirus - physiology | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Hepacivirus - drug effects | Virus Replication - drug effects | Antiviral Agents - pharmacology | Polyethylene Glycols | Antiviral Agents - therapeutic use | Interferon-alpha | Ribavirin - therapeutic use | Cell Proliferation - physiology | Cells, Cultured | Treatment Outcome | Hepatitis C, Chronic - drug therapy | CD8-Positive T-Lymphocytes - physiology | CD8-Positive T-Lymphocytes - drug effects | Benzimidazoles - pharmacology | Aged | Cell Proliferation - drug effects | Thiazoles - pharmacology | In Vitro Techniques | Oligopeptides - pharmacology | Virus Replication - physiology | Ribavirin - pharmacology | Interferon | Biological response modifiers | T cells | Hepatitis C | Health aspects
Journal Article
Nature reviews. Drug discovery, ISSN 1474-1784, 2020, Volume 19, Issue 3, pp. 149 - 150
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2010, Volume 54, Issue 5, pp. 1878 - 1887
Journal Article
Immunity (Cambridge, Mass.), ISSN 1074-7613, 2014, Volume 41, Issue 5, pp. 843 - 852
Journal Article
Journal of Virology, ISSN 0022-538X, 05/2006, Volume 80, Issue 10, pp. 5032 - 5040
Journal Article